Analyst Ratings for Cellectar Biosciences (CLRB)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/14/2025 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
0.24 (2.76) |
1050% | Details |
| 12/11/2024 | Oppenheimer » Updated 1/13/2025 |
Jeff Jones | Downgrade | Perform (Outperform) |
N/A (N/A) |
1.28 (2.76) |
115.63% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


